Moderna announces plan to expand commercial footprint in europe across six additional countries

Announcement reinforces moderna's commitment to europe and vision as a global commercial enterprise, building on the recent announcement of expansion in the asia-pacific region local commercial presence to be established in belgium, denmark, the netherlands, norway, poland, and sweden to support the delivery of mrna vaccines and therapeutics cambridge, ma / accesswire / february 16, 2022 / moderna, inc., (nasdaq:mrna) a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced plans to expand its commercial network across six additional countries in europe. moderna plans to establish a commercial presence in belgium, denmark, norway, the netherlands, poland, and sweden to support the delivery of mrna vaccines and therapeutics locally.
MRNA Ratings Summary
MRNA Quant Ranking